Name: SYKES & RAY EQUITIES (I) LTD.
Address: 3rd Floor, Cama Building, Dalal St, Kala Ghoda, Fort, Mumbai, 400001, IN
Telephone: 022 6193 7300

Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.

Beta Drugs Ltd.

Apr 17 NSE 1862.30(+ 40.80 2.24%)

Volume1680

Prev. Close
1821.50

Open Price
1800.05

Today's Low / High

1800.05 1871.95

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

1047.20 2214.35

(₹ in Crs.)

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	295.71	227.11	183.84	116.12	90.81
Total Operating Revenues	295.71	227.11	183.84	116.12	90.81

Other Income	1.36	0.75	0.76	0.50	0.41
Total Revenue	297.07	227.87	184.59	116.62	91.22

EXPENSES
Cost Of Materials Consumed	167.65	110.40	96.21	60.55	45.21
Operating And Direct Expenses	31.79	24.29	17.78	13.40	10.33
Changes In Inventories Of FG,WIP And Stock-In Trade	-18.24	-4.71	-1.75	-1.77	-0.85
Employee Benefit Expenses	25.89	22.70	15.91	10.88	9.46
Finance Costs	2.82	2.41	1.90	2.42	2.59
Depreciation And Amortisation Expenses	9.78	10.41	7.25	6.87	3.76
Other Expenses	28.63	21.31	12.99	8.31	8.75
Total Expenses	248.32	186.81	150.29	100.67	79.24

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	48.75	41.06	34.30	15.95	11.97

Profit/Loss Before Tax	48.75	41.06	34.30	15.95	11.97

Tax Expenses-Continued Operations
Current Tax	12.53	10.86	9.51	4.71	2.51
Deferred Tax	-0.21	-0.52	-0.03	-0.48	0.05
Total Tax Expenses	12.32	10.34	9.47	4.23	2.56
Profit/Loss After Tax And Before ExtraOrdinary Items	36.44	30.72	24.83	11.72	9.42

Profit/Loss From Continuing Operations	36.44	30.72	24.83	11.72	9.42

Profit/Loss For The Period	36.44	30.72	24.83	11.72	9.42
Consolidated Profit/Loss After MI And Associates	36.44	30.72	24.83	11.72	9.42

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	37.90	31.95	25.82	12.20	9.93
Diluted EPS (Rs.)	37.90	31.95	25.82	12.20	9.93

Particulars	Mar 24
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00

INCOME
Revenue From Operations [Net]	295.71
Total Operating Revenues	295.71
Other Income	1.36
Total Revenue	297.07
EXPENSES
Cost Of Materials Consumed	167.65
Operating And Direct Expenses	31.79
Changes In Inventories Of FG,WIP And Stock-In Trade	-18.24
Employee Benefit Expenses	25.89
Finance Costs	2.82
Depreciation And Amortisation Expenses	9.78
Other Expenses	28.63
Total Expenses	248.32
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	48.75
Profit/Loss Before Tax	48.75
Tax Expenses-Continued Operations
Current Tax	12.53
Deferred Tax	-0.21
Total Tax Expenses	12.32
Profit/Loss After Tax And Before ExtraOrdinary Items	36.44
Profit/Loss From Continuing Operations	36.44
Profit/Loss For The Period	36.44
Consolidated Profit/Loss After MI And Associates	36.44
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	37.90
Diluted EPS (Rs.)	37.90